TrialThe oncologist2026

A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer.

Julie N Graff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.